RHUMBLINE ADVISERS - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,300,597
-17.7%
93,512
+2.8%
0.01%
-16.7%
Q2 2023$5,227,068
+153141.5%
90,953
-0.0%
0.01%
+50.0%
Q1 2023$3,411
+44.3%
90,967
+7.8%
0.00%
+33.3%
Q4 2022$2,364
-99.9%
84,358
-0.3%
0.00%
-25.0%
Q3 2022$2,377,000
-13.7%
84,586
+6.8%
0.00%0.0%
Q2 2022$2,755,000
-4.1%
79,187
-1.0%
0.00%0.0%
Q1 2022$2,872,000
+58.1%
79,995
+2.6%
0.00%
+100.0%
Q4 2021$1,816,000
+21.8%
77,976
-0.6%
0.00%0.0%
Q3 2021$1,491,000
-19.0%
78,426
-14.1%
0.00%0.0%
Q2 2021$1,841,000
+19.2%
91,326
+8.4%
0.00%0.0%
Q1 2021$1,544,000
-7.0%
84,256
+2.0%
0.00%0.0%
Q4 2020$1,661,000
+7.3%
82,581
-0.0%
0.00%0.0%
Q3 2020$1,548,000
-21.3%
82,582
-5.8%
0.00%
-33.3%
Q2 2020$1,968,000
+42.1%
87,632
-6.1%
0.00%0.0%
Q1 2020$1,385,000
-37.3%
93,359
-18.5%
0.00%
-25.0%
Q4 2019$2,209,000
+2.3%
114,510
+5.1%
0.00%0.0%
Q3 2019$2,160,000
-4.9%
108,931
+1.3%
0.00%0.0%
Q2 2019$2,271,000
+4.8%
107,573
+1.4%
0.00%0.0%
Q1 2019$2,168,000
+4.8%
106,120
+2.1%
0.00%0.0%
Q4 2018$2,068,000
+22.4%
103,943
+18.3%
0.00%
+33.3%
Q3 2018$1,690,000
+24.0%
87,863
-1.7%
0.00%0.0%
Q2 2018$1,363,000
-12.6%
89,343
+7.4%
0.00%0.0%
Q1 2018$1,559,000
+0.5%
83,152
+3.1%
0.00%0.0%
Q4 2017$1,552,000
+21.9%
80,688
+13.3%
0.00%0.0%
Q3 2017$1,273,000
+2.2%
71,233
+2.1%
0.00%0.0%
Q2 2017$1,246,000
+26.6%
69,763
+2.8%
0.00%
+50.0%
Q1 2017$984,000
+13.5%
67,838
+44.1%
0.00%0.0%
Q4 2016$867,000
+3.8%
47,074
+7.0%
0.00%0.0%
Q3 2016$835,000
+49.9%
44,003
+27.3%
0.00%0.0%
Q2 2016$557,000
+28.0%
34,563
-4.7%
0.00%
+100.0%
Q1 2016$435,000
-12.1%
36,285
+4.3%
0.00%
-50.0%
Q4 2015$495,000
+30.6%
34,790
+7.4%
0.00%
+100.0%
Q3 2015$379,000
-29.7%
32,405
+5.6%
0.00%
-50.0%
Q2 2015$539,00030,6800.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders